Method for the production of fusion proteins in transgenic...

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S069100, C435S320100, C514S012200, C530S350000, C536S023500

Reexamination Certificate

active

07550263

ABSTRACT:
Desirable fusion proteins can be produced in and purified from the milk of transgenic animals. The peptides are made as fusion proteins with a suitable fusion partner such as human alpha-fetoprotein. The fusion partner protein acts to promote and increase the half-life of the overall molecule as well as having therapeutic effects on its own. The fusion protein is typically produced through the use of transgenic animals and can be purified away from the now the milk or other bodily fluid of such an animal by an affinity purification method. A particular advantage of producing peptides via this route, in addition to the obvious advantages of high yield and biocompatibility, is that specific post-translational modifications, such as carboxy terminal amidation, can be performed in the mammary gland. Biologically active polypeptides comprising a therapeutically active polypeptide fused to human alpha-fetoprotein fragment or a variant thereof, methods for the preparation thereof, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing said fusion polypeptides.

REFERENCES:
patent: 4399216 (1983-08-01), Axel et al.
patent: 4873316 (1989-10-01), Meade et al.
patent: 5322775 (1994-06-01), Clark et al.
patent: 5589604 (1996-12-01), Drohan et al.
patent: 5633076 (1997-05-01), Deboer et al.
patent: 5639940 (1997-06-01), Garner et al.
patent: 5648243 (1997-07-01), Hurwitz
patent: 5750172 (1998-05-01), Meade et al.
patent: 5780009 (1998-07-01), Karatzas et al.
patent: 5827690 (1998-10-01), Meade et al.
patent: 5831141 (1998-11-01), Lubon et al.
patent: 5843705 (1998-12-01), Ditullio et al.
patent: 5945577 (1999-08-01), Stice et al.
patent: 6201167 (2001-03-01), Pothier
patent: 6534479 (2003-03-01), Murgita
patent: 7122522 (2006-10-01), Andersen et al.
patent: WO 00/23472 (2000-04-01), None
patent: WO 01/00855 (2001-01-01), None
Alexander et al., Eur. J. Biochem. 178, 395-401 (1988).
Alexander et al., Nucleic Acids Res. 17, 6739 (1989).
Ausubel et al., Current Protocols in Molecular Biology, John Wiley & Sons, New York, NY, Chapters 9, 10, 12, 16, 1998.
Baguisi A,(1999) et al., Production of Goats by Somatic Cell Nuclear Transfer, Nature Biotech; 17: 456-461.
Benoist et al., The trp, recA, heat shock, and lacZ promoters ofE. coliand the SV40 early promote, Nature, 290:304-310, (1981).
Brignon et al., Febs Lett. 188, 48-55 (1977).
Campbell et al. Biol. Reprod. 49:933-942 (1993).
Campbell et al., Nucleic Acids Res. 12, 8685-8697 (1984).
Campbell et al., Nature 385:810-813 (1996).
Cibelli JB, (1998) et al., Cloned Transgenic Calves Produced From Nonquiescent Fetal Fibroblasts. Science; 280: 1256-1258.
Clark et al., Biotechnology 7: 487-492 (1989).
Cosman et al., Letters to Nature, 312: 768, (1984).
Cosman et al., Mol. Immunol., 23:935, (1986).
DiTullio, Biotechnology 10:74-77 (1992).
Eipper BA, et al., Peptidylglycine alpha-Amidating Monooxygenase: A Multifunctional Protein with Catalytic, Processing and Routing Domains, (1993) Protein Science 2, 489-49.
Eppstein et al., Biochemical and Biophysical Research Communications, 120:66-73 (1984).
Fisher, Laboratory Techniques in Biochemistry and Molecular Biology,DNA Sequencing, eds. Work and Burdon, Elsevier, vol. 10, 1983.
Goeddel, Gene Expression Technology: Methods in Enzymology 185, (Academic Press, San Diego, Calif. (1990).
Gorodetsky et al., Gene 66, 87-96 (1988).
Gordon et al., Biotechnology 5: 1183-1187 (1987).
Hall, Biochem. J. 242, 735-742 (1987).
Hobbs et al., J. Biol. Chem. 257:3598-3605 (1982).
Huber et al., Adv. Drug Delivery Reviews 17:279-292, 1995.
Hwang, H.-Y, et al., (1996). Creation of Homozygous Mutants of Leishmania Donovani With Single Targeting Constructs. J. Biol. Chem. 271: 30840-30846.
Ivanov et al., Biol. Chem. Hoppe-Seyler 369, 425-429 (1988).
Jain, M, et al., (2001). Targeted Inactivation of G•I Does Not Alter Cardiac Function or •-Adrenergic Sensitivity. Am. J. Physiol. 280: 569H-575.
Jamieson et al., Gene 61, 85-90 (1987).
Jones et al., J. Biol. Chem. 260, 7042-7050 (1985).
Jones et al., J. Biol. Chem. 265:14684-14690, 1990.
Kanehisa (1984) Nuc. Acids Res. 12:203-213.
Kasinathan P,(2001) et al., Effect of Fibroblast Donor Cell Age and Cell Cycle on Development of Bovine Nuclear Transfer Embryos In Vitro, Biol Reprod.; 64(5): 1487-1493.
Kasinathan P, (2001) et al., Production of Calves from G1 Fibroblasts, Nature Biotech; 19: 1176-1178.
Lambda II, (ed. R. Hendrix, J. Roberts, F. Stahl, and R. Wesiberg), pp. 145-173, 209-250, 395-466, (1983).
Lim, S, et al., (1997). A Shortened Life Span of EKLF-/- Adult Erythrocytes, Due to a Deficiency of Beta -Globin Chains, is Ameliorated by Human Gamma—Globin Chains. Blood 90.
McGrane et al., TIBS 17:40-44, 1992.
Meng L, et al., (1997) Rhesus Monkeys Produced by Nuclear Transfer, Biol Reprod. Aug. 57(2):454-9.
Mercier & Vilotte, J. Dairy Sci. 76, 3079-3098 (1993).
Morinaga et al. (Proc. Natl. Acad. Sci. USA 80:4604-4608, (1983).
Mortensen, R, et al., (1992) Production of Homozygous Mutant ES Cells with a Single Targeting Construct. Mol.Cell. Biol. 12, 2391-2395.
Nagy, A, et al., (1996) Targeted Mutagenesis: Analysis of Phenotype Without Germ-Line Transmission. J. Clin. Invest. 97: 1360-1365.
Okayama et al., Mol. Cell. Biol., 3:280, (1983).
Ongeri EM, et al., (2001) Development of Goat Embryos After In vitroFertilization and Parthenogenetic Activation by Different Methods, Theriogenology Jun. 1;55(9):1933-45.
Paris et al., Biotechnol. Appl. Biochem. 12:436-449 (1990).
Pearse and Takor,Embryology of the diffuse neuroendocrine system and its relationship to the common peptides, Fed. Proc., 38(9) 2288-94, 1979.
Remington's Pharmaceutical Sciences, 16thed., Osol, A., editor; Mack, Easton Press., Chapter 89, 95-100, 1035-1038, 1411,-1712, 1980.
Richards et al., J. Biol. Chem. 256, 526-532 (1981).
Sakai, E, et al., (1999). Recombination And Transcription of The Endogenous Ig Heavy Chain Locus Is Effected by the Ig Heavy Chain Intronic Enhancer Core Region In the Absence of the Matrix Attachment Regions. Proc. Natl. Acad. Sci. U.S.A. 96: 1526-1531.
Sambrook et al., (1989). Molecular Cloning—A Laboratory Manual, 2nd Ed., ed. (Cold Spring Harbor Laboratory Press.
Shen et al., DNA 8:101-108, 1989.
Shimada et al., Febs Letters 279:198-200, 1991.
Soulier et al., Febs Letts. 297:13 (1992).
Stewart, Nucleic Acids Res. 12:3895-3907, 1984.
Tan et al., Dev. Biol. 146:24-37, 1991.
Vilotte et al., Biochimie 69, 609-620 (1987).
Watson et al. (1987) in The Molecular Biology of the Gene (4th ed.) Chapter 19, 595-617, (1987).
Wilmut I, et al., (2002) Somatic Cell Nuclear Transfer, Nature Oct. 10;419(6907):583-6.
Wilmut I, et al., (1997) Viable Offspring Derived From Fetal and Adult Mammalian Cells, Nature Feb. 27;385(6619):810-3.
Wold F., et al., In vivo Chemical Modification of Proteins, Ann. Rev. Biochem. 50 783-814 (1981).
Wright et al., High Level Expression of Active Human alpha-1-Antitrypsin in the Milk of Transgenic Sheep, (1991) Bio/Technology, 9 77-84.
Yong Z and L Yuqiang, (1998) Nuclear-Cytoplasmic Interaction and Development of Goat Embryos Reconstructed by Nuclear Transplantation: Production of Goats by Serially Cloning Embryos, Biol Reprod.; 58: 266-269.
Yu-Lee & Rosen, J. Biol. Chem. 258, 10794-10804 (1983).
Zbikowska, et al., Biochem. J. 365:7-11, 2002.
Zbikowski et al., Transgenic Res. 11:425-435, 2002.
Zou X, et al.,(2002) Generation of Cloned Goats (Capra Hircus) From Transfected Foetal Fibroblast Cells, The Effect of Donor Cell Cycle, Mol Reprod Dev.; 61: 164-172.
Chou et al., Expression of Chimeric monomer and Dimer Proteins on the Plasma Membrane of Mammalian Cells. iotechnology and Bioengineering. 1999, vol. 65, pp. 160-169.
Gluzman SV40-transformed simian cells support the replication of early SV40 mutants. Cell. Jan. 1981;23(1):175-82.
Kerr et al. The bladder as a bioreactor: urothelium production and secretion of growth hormone into urine. Nat. Biotechnology. 1998 16: 75-79.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for the production of fusion proteins in transgenic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for the production of fusion proteins in transgenic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the production of fusion proteins in transgenic... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4111549

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.